Pap, Akos F

Connor, Philip; Sánchez van Kammen, Mayte; Lensing, Anthonie W A; Chalmers, Elizabeth; Kállay, Krisztián; Hege, Kerry; Simioni, Paolo; Biss, Tina; Bajolle, Fanny; Bonnet, Damien; Grunt, Sebastian; Kumar, Riten; Lvova, Olga; Bhat, Rukhmi; Van Damme, An; Palumbo, Joseph; Santamaria, Amparo; Saracco, Paola; Payne, Jeanette; Baird, Susan; ... (2020). Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT). Blood advances, 4(24), pp. 6250-6258. American Society of Hematology 10.1182/bloodadvances.2020003244

Male, Christoph; Lensing, Anthonie W A; Palumbo, Joseph S; Kumar, Riten; Nurmeev, Ildar; Hege, Kerry; Bonnet, Damien; Connor, Philip; Hooimeijer, Hélène L; Torres, Marcela; Chan, Anthony K C; Kenet, Gili; Holzhauer, Susanne; Santamaría, Amparo; Amedro, Pascal; Chalmers, Elizabeth; Simioni, Paolo; Bhat, Rukhmi V; Yee, Donald L; Lvova, Olga; ... (2020). Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. The Lancet. Haematology, 7(1), e18-e27. Elsevier 10.1016/S2352-3026(19)30219-4

Beyer-Westendorf, Jan; Lensing, Anthonie W A; Arya, Roopen; Bounameaux, Henri; Cohen, Alexander T; Wells, Philip S; Middeldorp, Saskia; Verhamme, Peter; Hughes, Rodney; Kucher, Nils; Pap, Akos F; Trajanovic, Mila; Prins, Martin H; Prandoni, Paolo; Weitz, Jeffrey I (2017). Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials. Thrombosis research, 149, pp. 29-37. Elsevier 10.1016/j.thromres.2016.11.014

Di Nisio, Marcello; Ageno, Walter; Rutjes, Anne W S; Pap, Akos F; Büller, Harry R (2016). Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists. Thrombosis and haemostasis, 115(2), pp. 424-432. Schattauer 10.1160/TH15-06-0474